{
  "id": "nafld_activity_score",
  "title": "NAFLD (Non-Alcoholic Fatty Liver Disease) Activity Score",
  "description": "Diagnoses steatohepatitis based on histological findings in NAFLD patients. The NAS evaluates disease activity by scoring three histological features: steatosis, lobular inflammation, and hepatocellular ballooning.",
  "category": "gastroenterology",
  "version": "2005",
  "parameters": [
    {
      "name": "steatosis",
      "type": "string",
      "required": true,
      "description": "Percentage of hepatocytes containing fat droplets on liver biopsy",
      "options": ["<5%", "5-33%", "34-66%", ">66%"],
      "validation": {
        "enum": ["<5%", "5-33%", "34-66%", ">66%"]
      }
    },
    {
      "name": "lobular_inflammation",
      "type": "string",
      "required": true,
      "description": "Number of inflammatory foci per 200× microscopic field",
      "options": ["No foci", "1 focus per 200× field", "2-4 foci per 200× field", ">4 foci per 200× field"],
      "validation": {
        "enum": ["No foci", "1 focus per 200× field", "2-4 foci per 200× field", ">4 foci per 200× field"]
      }
    },
    {
      "name": "ballooning",
      "type": "string",
      "required": true,
      "description": "Hepatocellular ballooning (enlarged hepatocytes with rarefied cytoplasm)",
      "options": ["None", "Few balloon cells", "Many cells/prominent ballooning"],
      "validation": {
        "enum": ["None", "Few balloon cells", "Many cells/prominent ballooning"]
      }
    }
  ],
  "result": {
    "name": "nafld_activity_score",
    "type": "integer",
    "unit": "points",
    "description": "NAFLD Activity Score ranging from 0-8"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 0,
        "max": 0,
        "stage": "No activity",
        "description": "No NAFLD activity",
        "interpretation": "Score of 0 indicates no evidence of NAFLD activity. No steatosis, inflammation, or hepatocellular ballooning present."
      },
      {
        "min": 1,
        "max": 2,
        "stage": "Mild activity",
        "description": "Mild NAFLD activity",
        "interpretation": "NAS of 1-2 indicates mild NAFLD activity. Generally correlated with 'not NASH' diagnosis. Close monitoring recommended."
      },
      {
        "min": 3,
        "max": 5,
        "stage": "Moderate activity",
        "description": "Moderate NAFLD activity",
        "interpretation": "NAS of 3-5 indicates moderate NAFLD activity. Scores ≥4 have optimal sensitivity and specificity for predicting steatohepatitis. NAS ≥5 strongly correlates with 'definite NASH' diagnosis."
      },
      {
        "min": 6,
        "max": 8,
        "stage": "Marked activity",
        "description": "Marked NAFLD activity",
        "interpretation": "NAS of 6-8 indicates marked NAFLD activity. Strongly correlates with definite NASH diagnosis. Consider therapeutic intervention and close monitoring."
      }
    ]
  },
  "references": [
    "Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005 Jun;41(6):1313-21. doi: 10.1002/hep.20701.",
    "Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA; NASH Clinical Research Network (CRN). Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology. 2011 Mar;53(3):810-20. doi: 10.1002/hep.24127."
  ],
  "formula": "NAS = Steatosis score (0-3) + Lobular inflammation score (0-3) + Hepatocellular ballooning score (0-2)",
  "notes": [
    "The NAS should not be used as a standalone diagnostic tool for NASH",
    "A ≥2-point improvement in NAS is commonly used as an endpoint in clinical trials",
    "Fibrosis is staged separately (0-4) and is not included in the NAS",
    "NAS ≥4 is recommended for admission into interventional trials for NASH"
  ]
}